Mario Gabelli's JNJ Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 82,375 shares of Johnson & Johnson (JNJ) worth $15.27 M, representing 0.15% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Mario Gabelli has maintained a long-term strategic position in JNJ, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2022, adding 40,201 shares. Largest reduction occurred in Q4 2017, reducing 40,299 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Johnson & Johnson (JNJ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Johnson & Johnson (JNJ) Trades by Mario Gabelli
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +406,105 | Add 0.00% | 406,104 | $85.86 |
| Q3 2013 | +3,317 | Add 0.82% | 409,421 | $86.69 |
| Q4 2013 | +2,376 | Add 0.58% | 411,797 | $91.59 |
| Q1 2014 | -16,736 | Reduce 4.06% | 395,061 | $98.23 |
| Q2 2014 | -21,875 | Reduce 5.54% | 373,186 | $104.62 |
| Q3 2014 | -6,820 | Reduce 1.83% | 366,366 | $106.59 |
| Q4 2014 | -29,431 | Reduce 8.03% | 336,935 | $104.57 |
| Q1 2015 | -3,780 | Reduce 1.12% | 333,155 | $100.60 |
| Q2 2015 | -18,005 | Reduce 5.40% | 315,150 | $97.46 |
| Q3 2015 | +2,697 | Add 0.86% | 317,847 | $93.35 |
| Q4 2015 | +14,440 | Add 4.54% | 332,287 | $102.72 |
| Q1 2016 | +5,301 | Add 1.60% | 337,588 | $108.20 |
| Q2 2016 | -24,757 | Reduce 7.33% | 312,831 | $121.30 |
| Q3 2016 | -18,704 | Reduce 5.98% | 294,127 | $118.13 |
| Q4 2016 | -36,541 | Reduce 12.42% | 257,586 | $115.21 |
| Q1 2017 | +2,869 | Add 1.11% | 260,455 | $124.55 |
| Q2 2017 | -4,170 | Reduce 1.60% | 256,285 | $132.29 |
| Q3 2017 | -8,610 | Reduce 3.36% | 247,675 | $130.01 |
| Q4 2017 | -40,299 | Reduce 16.27% | 207,376 | $139.72 |
| Q1 2018 | -16,625 | Reduce 8.02% | 190,751 | $128.15 |
| Q2 2018 | -7,657 | Reduce 4.01% | 183,094 | $121.34 |
| Q3 2018 | -1,106 | Reduce 0.60% | 181,988 | $138.17 |
| Q4 2018 | -9,621 | Reduce 5.29% | 172,367 | $129.05 |
| Q1 2019 | -26,863 | Reduce 15.58% | 145,504 | $139.79 |
| Q2 2019 | +16,345 | Add 11.23% | 161,849 | $139.28 |
| Q3 2019 | -5,126 | Reduce 3.17% | 156,723 | $129.38 |
| Q4 2019 | -16,830 | Reduce 10.74% | 139,893 | $145.87 |
| Q1 2020 | -6,380 | Reduce 4.56% | 133,513 | $131.13 |
| Q2 2020 | -10,118 | Reduce 7.58% | 123,395 | $140.63 |
| Q3 2020 | -4,475 | Reduce 3.63% | 118,920 | $148.88 |
| Q4 2020 | -3,250 | Reduce 2.73% | 115,670 | $157.38 |
| Q1 2021 | -5,974 | Reduce 5.16% | 109,696 | $164.35 |
| Q2 2021 | -4,593 | Reduce 4.19% | 105,103 | $164.74 |
| Q3 2021 | -2,403 | Reduce 2.29% | 102,700 | $161.50 |
| Q4 2021 | -897 | Reduce 0.87% | 101,803 | $171.07 |
| Q1 2022 | -4,460 | Reduce 4.38% | 97,343 | $177.23 |
| Q2 2022 | +40,201 | Add 41.30% | 137,544 | $177.51 |
| Q3 2022 | +17,607 | Add 12.80% | 155,151 | $163.36 |
| Q4 2022 | +757 | Add 0.49% | 155,908 | $176.65 |
| Q1 2023 | -14,625 | Reduce 9.38% | 141,283 | $155.00 |
| Q2 2023 | -8,199 | Reduce 5.80% | 133,084 | $165.52 |
| Q3 2023 | -19,588 | Reduce 14.72% | 113,496 | $155.75 |
| Q4 2023 | -5,354 | Reduce 4.72% | 108,142 | $156.74 |
| Q1 2024 | -3,679 | Reduce 3.40% | 104,463 | $158.19 |
| Q2 2024 | -6,101 | Reduce 5.84% | 98,362 | $146.16 |
| Q3 2024 | -1,781 | Reduce 1.81% | 96,581 | $162.06 |
| Q4 2024 | -3,647 | Reduce 3.78% | 92,934 | $144.62 |
| Q1 2025 | -6,220 | Reduce 6.69% | 86,714 | $165.84 |
| Q2 2025 | -132 | Reduce 0.15% | 86,582 | $152.75 |
| Q3 2025 | -4,207 | Reduce 4.86% | 82,375 | $185.42 |
Mario Gabelli's Johnson & Johnson Investment FAQs
Mario Gabelli first purchased Johnson & Johnson (JNJ) in Q2 2013, acquiring 406,104 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Johnson & Johnson (JNJ) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli's largest addition to Johnson & Johnson (JNJ) was in Q2 2013, adding 406,104 shares worth $34.87 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 82,375 shares of Johnson & Johnson (JNJ), valued at approximately $15.27 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Johnson & Johnson (JNJ) represents approximately 0.15% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli's peak holding in Johnson & Johnson (JNJ) was 411,797 shares, as reported at the end of Q4 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.